Search - tctmd.com

Displaying 301 - 320 of 499

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

August 22, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

One in Four ICD Patients Need Reintervention Within 5 Years

Ashley Lyles

August 04, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Daily News

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Yael L. Maxwell

June 26, 2017

News Daily News

Athletes With ICDs May Still Compete, Study Reassures

Ashley Lyles

June 06, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Industry News

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

May 09, 2017

Presentation SWVS 2017

Cases: The Good, The Bad and The Ugly

Presenter: Michael J. Reardon

May 07, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Presentation

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

April 12, 2017

News Daily News

FDA: Class I Recall for Over 47,000 HeartStart MRx Monitor/Defibrillator Units

L.A. McKeown

March 24, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Industry News

Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers

February 28, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Todd Neale

February 16, 2017

Presentation JIM 2017

Lithoplasty for treatment of Calcified Coronary Disease: The results of the DISRUPT CAD study

Presenter: Todd J. Brinton

February 10, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Industry News

Abbott Announces U.S. Approval for Its Assurity MRI™ Pacemaker, The World’s Smallest, Longest-Lasting Wirelless MRI-Compatible Pacemaker

February 01, 2017

Advertisement

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

One in Four ICD Patients Need Reintervention Within 5 Years

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short

Athletes With ICDs May Still Compete, Study Reassures

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

Cases: The Good, The Bad and The Ugly

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

FDA: Class I Recall for Over 47,000 HeartStart MRx Monitor/Defibrillator Units

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Both Appropriate and Inappropriate ICD Shocks Prompt Substantial Use of Healthcare Resources

Lithoplasty for treatment of Calcified Coronary Disease: The results of the DISRUPT CAD study

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Abbott Announces U.S. Approval for Its Assurity MRI™ Pacemaker, The World’s Smallest, Longest-Lasting Wirelless MRI-Compatible Pacemaker

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content